B.Pharma Jobs, M.Pharma Jobs, Pharma Jobs

Wipro Hiring M.Pharm,B.Pharma,BAMS,BHMS for Drug Safety Associates-Apply Now

Wipro Walk In Interview 2022  M.Pharm / B.Pharma / BAMS / BHMS / PhD./ Pharm D / BDS for Drug Safety Associates At Pune,India. Wipro Notification full details below..Interested and eligible candidates can attend interview on scheduled time and venue.

  • Vacancy details:
  • Post Name: Drug Safety Associates
  • Qualification: M.Pharm / B.Pharma / BAMS / BHMS / PhD./ Pharm D / BDS   
  • Experienced:NA
  • Openings:NA
  • Salary:NA

Job Description: Wipro Hiring For Drug Safety Associates !

  • Important Details :
  • Location: Pune,India
  • Post of date:06/05/2022
  • Selection Process: The selection will be on the basis of Interview.

Job description

Job Description 1. Reviewing the published reports/biomedical literature to ascertain if they contain individual case reports and Non-individual case reports. 2. Applying regulatory and internal guidance to determine if the article meets the definition of a valid case report and Non- individual case reports. 3. Write accurate and concise summaries that capture the key elements from these published reports 4. Ensure consistent coding of medical history, drugs and adverse event terms 5. Evaluation of Serious Adverse Event to ensure accurate processing from source documents with emphasis on quality and timeliness 6. Creating summary content in a range of formats (narrative summaries, structured database inputs, electronic formats for regulatory filing) to support the drug safety reporting and information requirements of pharma industry client

About Company:

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. 

Apply Now

Related Posts

Leave a Reply

Your email address will not be published.